Back to Study Material Artificial Intelligence

AI in healthcare

Artificial intelligence is reshaping healthcare across the entire clinical pipeline, from early disease detection to treatment planning, drug discovery, an...

AI in healthcare

Transforming Medicine with Intelligence

Artificial intelligence is reshaping healthcare across the entire clinical pipeline, from early disease detection to treatment planning, drug discovery, and hospital operations. The healthcare domain is particularly rich with complex, high-dimensional data including medical images, genomic sequences, electronic health records, and continuous physiological signals from wearable devices, making it a natural application area for sophisticated machine learning models.

Medical imaging is the most mature area of AI in healthcare. Convolutional neural networks trained on large annotated datasets have achieved performance comparable to board-certified radiologists at detecting diabetic retinopathy from fundus photographs, identifying cancerous nodules in lung CT scans, and classifying skin lesions from dermoscopic images. Google's DeepMind developed an AI system for diagnosing over fifty eye diseases from optical coherence tomography scans with expert-level accuracy, and the system was validated across diverse patient populations.

In drug discovery, AI accelerates the identification of promising drug candidates by predicting molecular properties, simulating protein-drug interactions, and generating novel molecular structures with desired characteristics. DeepMind's AlphaFold2 solved the fifty-year-old protein structure prediction problem, generating accurate three-dimensional protein structures from amino acid sequences with accuracy comparable to expensive experimental crystallography. This breakthrough opens new avenues for understanding disease mechanisms and designing targeted therapies.

Clinical Decision Support

AI-powered clinical decision support systems analyse patient records, lab results, and medication histories to alert clinicians to potential drug interactions, flag deteriorating patients before crisis points, and suggest evidence-based treatment options. Sepsis prediction models that issue early warnings hours before clinical deterioration have been shown to reduce mortality in intensive care settings.

Exam Tip

Healthcare AI questions often ask about barriers to deployment beyond technical performance. Key barriers include regulatory approval requirements such as FDA clearance in the United States, liability questions when AI recommendations are followed and outcomes are poor, data privacy under HIPAA and GDPR, and algorithmic bias when training data does not represent all patient demographics. Structuring an answer around technical, regulatory, ethical, and organisational dimensions demonstrates comprehensive understanding.